Cooley advised Gracell Biotechnologies; and Davis Polk & Wardwell advised the placement agents on the deal.Gracell Biotechnologies Inc. (Nasdaq: GRCL) announced that it has entered into a purchase…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
